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During the past several years, this laboratory has been involved in the study of the 
unique mixed-lymphocyte reaction (MLR) 1 stimulating determinants and restriction 
elements  for antigen  presentation,  which  are  associated  with  (C57BL/6  ×  A/J)Fa 
[(B6A)F1]  spleen cells when used as stimulator cells or antigen-presenting cells (1).  A 
considerable amount of data has been accumulated strongly suggesting that these F1- 
specific MLR-stimulating determinants and restriction elements are in fact hybrid Ia 
molecules.  Because each Ia molecule is composed of one alpha and one beta chain, 
hybrid molecules can be formed in heterozygous cells by the random association of 
alpha and beta chains encoded by the two parental haplotypes (2). Thus, in (B6A)F1 
k  k  AkAb  AbAk  (If there is more  cells there are four possible I-A molecules: A~A~,  b  b  A~Aa, ~B,~B. 
than  one  gene  each  for  A~  and  A~  chains,  then  the  number  of possible  hybrid 
molecules increases accordingly.)  Using alloreactive T  cell clones of A  strain  (I-A  k) 
origin,  it  should  be possible  to  identify  clones  that  react  with  three  of these  four 
combinations  of A  region  alpha  and  beta  Chains;  the  A~A~ molecule  will  not  be 
recognized because it is "self". On the other hand, it is expected that antigen-reactive 
T  cell  clones  of  (B6A)F1  or  (B6  X  C3H)F1  origin  will  be  able  to  use  all  four 
combinations as restriction elements in antigen presentation. 
In the experiments that follow, we will show that we can discriminate two different 
classes of A  anti-(B6A)F1  alloreactive and two different classes of (B6A)F1  or (B6  X 
C3H)Fa antigen-reactive T  cell clones with specificity for the two hybrid I-A molecules 
discussed above. This discrimination is based on experiments using monoclonal anti- 
I-A antibodies  to block the MLR and experiments using spleen cells from the  LA  b 
mutant  mouse strain B6.C-H-2  b:mz (bml2)  as stimulator cells.  Previously  (3,  4), we 
have shown that there exist antigen-reactive T  cell clones that use either I-A  b, I-A  k, or 
hybrid  I-Ab/I-A  k molecules  as  restriction  elements  in  antigen  recognition.  In  this 
report, we will provide evidence that among the hybrid I-Ab/I-Ak-specific clones, we 
can discriminate those recognizing A~A~ and AbA~. 
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Materials  and  Methods 
Mice.  Adult mice of either sex from 6 wk to 6 mo of age were used in all experiments. All 
mice were bred in our facilities at the Mayo Clinic or Stanford University or purchased from 
The Jackson Laboratory (Bar Harbor, ME).  The recombinant  and  mutant  mice used were 
generously provided by Dr. Chella David, Mayo Medical School, Rochester, MN. 
Culture Medium.  Complete culture medium consisted of RPMI  1640  (Gibco Laboratories, 
Grand Island Biological Co., Grand Island, NY) containing 10% fetal calf serum (FCS), 5 × 
10  -5 M  2-mercaptoethanol, 10 mM Hepes, 100 U/ml penicillin, and  100 pg/ml streptomycin. 
L-glutamine was added to a  final concentration of 2  ×  10  -~ M  before use. The alloreactive 
clones in the  11  series, e.g.,  11.17,  were maintained and assayed in medium containing  10% 
horse serum instead of 10% FCS. 
Cell Lines.  The alloreactive cell lines were maintained as has been described previously (5), 
except that cloned lines usually required the addition of 0.5-1% rat eoncanavalin A  (Con A) 
supernatant  factor when  recultured every  10-14  d.  The  rat  Con  A  supernatant  factor was 
prepared as described (5). The myoglobin-reactive clone 26.17  and the keyhole limpet hemo- 
cyanin (KLH) -reactive clones 9 and 11 have been described elsewhere (3, 4). 
Proliferation Assay.  The [3H]thymidine incorporation proliferation assay was performed as 
described previously (5).  To  test  the ability of various antibody preparations to block the 
proliferative response, a small amount of antibody (~2.0 #g/well) was added to the appropriate 
wells in the standard assay system. Specificity of blocking was controlled by testing the same 
antibody against an inappropriate responder clone. 
k  Antibodies.  The  monoclonal  anti-I-A  antibodies  H150.13,  Hl16.32,  and  Hl18.49  were 
described previously (6,  7).  Antibody  10-2.16  was obtained from  Dr.  Vernon  Oi,  Stanford 
University (8). Monoclonal antibodies were purified by affinity chromatography on protein A 
sepharose and  brought  to  1.0  mg/ml  in  phosphate-buffered saline. Antiserum D-33  [(A × 
B10.D2)F1 anti-B10.A(5R)] was a contract antiserum obtained from the National Institutes of 
Health. This antiserum contains antibodies reactive with both K b and I-A  b molecules. 
Two-dimensional Gel Analyses of Ia Molecules.  Ia molecules were biosynthetically labeled and 
isolated as described previously (9). Briefly, spleen cells were teased into a single-cell suspension 
and  incubated with  S-methionine (1  mCi/ml)  for 5  h  at  37°C  in a  solution consisting of 
methionine-free Dulbecco's modified Eagle's medium, 5% dialyzed FCS, and  10 mM Hepes. 
Cells were solubilized at ~2 ×  10  v cells/ml in 0.5% Triton X-100, and cell debris removed by 
centrifugation. Extracts (usually 100 pl) were precipitated with either monoclonal antibodies or 
antisera, and the complexes were adsorbed to fixed Staphylococcus aureus bacteria. Precipitates 
were eluted directly into lysis buffer (9.5 M  urea, 2% Triton X-100, 1.6% ampholines, pH 5-7, 
0.4%  ampholines, pH 3.5-10, and 5%  2-mercaptoethanol) and then analyzed by two-dimen- 
sional gel analysis as described (9). 
Results 
Monoclonal Anti-I-A k Antibodies Block Proliferation of  Alloreactive  T Cell Clones.  We have 
previously described  (1,  10)  several  alloreactive A  anti-(B6A)F1 T  cell clones with 
different spectra of reactivities against stimulator cells of various haplotypes. Among 
these  is a  group  of clones that  appear,  by mapping experiments,  to be specific for 
alloantigens  that  are  controlled  by  the  I-A  region  of  the  H-2  complex.  Using 
monoclonal  anti-Ia  antibodies,  we  have  studied  the  relationship  between  the  I-A 
determinants recognized by the T  cell clones and the I-A determinants recognized by 
alloantibodies. 
In Table I  we present  data on  the  ability of four different  anti-I-A  k monoclonal 
antibodies  to  block  the  proliferative response  of four  alloreactive T  cell  clones  to 
(B6A) F1 splenic stimulator cells. All of these alloreactive clones were obtained from A 
anti-(B6A)F1 bulk cultures by cloning either in soft agar or by limiting dilution (5). 
Clones 11.17,  1 I. 19,  10.39.2, and 23AB 1.2 are specific for I-Ak/I-A  b hybrid molecules, 
which can be seen from the data presented in Table II. A  similar clone,  1.8.16,  has 1 188  T  CELL  CLONES  SPECIFIC  FOR  HYBRID  I-A  MOLECULES 
TABLE  I 
Inhibition of MLR Stimulation by Monoclonal Anti-I-A k Antibodies 
Clones 
23  11.17  11.19  10.39.2  ABI.2 
No antibody  14,482  5,393  6,727  15,588 
Hl50.13  ala. 17  178  63  5,403  12,299 
10-2.16  Ma. t7  108  75  4,141  10,569 
Hl16.32  ~Ia.19  14,326  4,424  517  4,852 
Hl18.49  aIa.2  14,591  6,270  946  NT 
The response,  as cpm of [aH]thymidine  incorporated, on  day  2 of 1 ×  10  4 
cloned responder cells to  1 ×  106  irradiated (B6A)F1 stimulator cells in the 
presence of various monoclonal antibodies. 
TABLE  II 
Stimulation of Alloreactive Clones by [bml2  X  BIO.A (4R)]Fa  Cells 
Stimulator cells 
Haplotypes  Clones 
K  A  E  D  11.17  11.19  10.39.2  23ABI.2 
A  k  k  k  d  117  120  302  639 
B6  b  b  b  b  161  232  737  1,693 
(B6 × A)F1  b  b  b  b  24,821  8,180  11,120  19,975 
~  k  d 
[S6 x  B10.A(4R)]F,  b  b  b  b  21,927  9,708  11,541  17,504 
~  b  b 
[bml2 × BI0.A(4R)]F1  b  b*  b  b  12,761  6,612  1,603  1,788 
T  b  b 
The response, as cpm of [3H]thymidine  incorporation, on day 2 of 2 ×  104 cloned responder cells to 1 × 
106 irradiated (3,300 rad)  stimulator cells. 
* The bml2 mouse has a mutation in the A¢ chain (16). 
TABLE  III 
Inhibition of Antigen Recognition by Monoclonal Anti-I-A k Antibodies 
Clones 
26.17  9 KLH  11  KLH  myoglobin 
No antibody  37,4t0  18,089  24,284 
H 150.13  Ma. 17  20,237  NT*  NT 
10-2.16  Ma. 17  17,700  0  28,312 
H 116.32  Ma. 19  658  15,941  7,252 
H 118.49  Ma.2  703  NT  NT 
The response,  as cpm of [~H]thymidine  incorporated, on day 3 of 1 ×  104 
cloned responder cells to 3/IM myoglobin or 50/~g/ml KLH in the presence 
of 1 X 106 irradiated (3,300 rad) syngeneic spleen cells. 
* Not tested. 
been described previously (1,  1 1).  The  antibody-blocking data  presented in  Table  I 
indicate that  these four clones represent two different types. Clones  11.17  and  11.19 
are blocked by antibodies H  150.13 and  10-2.16, which are Ia. 17  reagents, and are not 
blocked  by  Hl16.32  and  Hl18.49,  which  are  Ia. 19  and  Ia.2  reagents, respectively. BECK  ET  AL.  1189 
Clones  10.39.2  and  23AB1.2  display  the  reciprocal pattern  of blockade.  We  have 
found that  all  other alloreactive Fx-specific clones  restricted  to  I-A tested  to  date 
follow one or the other of these two patterns. 
Monoclonal Anti-I-A k Antibodies Block Proliferation of Antigen-reactive T  Cell Clones.  We 
have  also  used  these  monoclonal  anti-I-A  k  antibodies  to  block  the  proliferative 
response of soluble antigen-reactive T  cell clones.  Myoglobin-reactive clone 26.17, 
which is of (B6A)F1  origin, recognizes myoglobin when this antigen is presented by 
spleen cells from mice that  are  I-Ak/I-A  b heterozygotes (3).  As  is  demonstrated  in 
Table III, antigen recognition by this clone can be blocked by antibodies Hl16.32 
and  Hl18.49,  but  not  by H150.13  or  10-2.16.  KLH-reactive clone  11  also  can  be 
blocked by  Hl16.32,  but  not  by  10-2.16,  whereas  clone  9  displays  the  reciprocal 
pattern. These KLH-reactive clones are of (B6 ×  C3H)F1 origin and recognize antigen 
when presented by I-Ab/I-A  k heterozygous cells (4).  Thus, myoglobin=reactive clone 
26.17 and KLH-reactive clone 11 display the same pattern of antibody blockade as 
the alloreactive clones  10.39.2  and 23AB1.2, whereas KLH-reactive clone 9 displays 
the same pattern as alloreactive clones 11.17 and  11.19. 
Biochemical Evidence that Monoclonal Anti-I-A k Antibody  10-2.16 Recognizes a Determinant 
of A~ Chains, whereas Antibody Hl16.32 RecognizesA~  Chains.  Antibody 10-2.16 appears 
to recognize a determinant on the A~ chain (12). The ability of this antibody to block 
alloreactive clones  11.17  and  11.19  and  KLH-reactive clone 9  suggests  that  these 
clones (and antibody 10-2.16)  recognize the  b  k  •  A,At~ hybrid molecule. Because alloreac- 
tive clones  10.39.2  and 23AB1.2, myoglobin-reactive clone 26.17, and KLH-reactive 
clone 11 are not blocked by 10-2.16,  but are inhibited by H116.32, these clones (and 
antibody H116.32) must recognize a  different determinant on a  hybrid I-A  b/k mole- 
cule. This second determinant might be a different site on the A~bA~ molecule or a site 
on the reciprocal hybrid I-A molecule, A~A~. 
We examined the I-A molecules precipitated by antibodies  10-2.16 and Hl16.32. 
Both of these monoclonal antibodies recognize spleen cells of haplotype k  but  not 
haplotype b (6, 8). Assuming that the I-A a  and fl polypeptides can freely associate in 
(BbA)F1  (b  X  k)  cells  and  that  antibodies  reacting  with  one  chain  (e.g.,  a)  will 
precipitate the corresponding chain  ~)  through noncovalent association, we sought 
to distinguish whether antibody Hl16.32 recognized the same molecular complex as 
10-2.16  b  k  (A,A~)  or the reciprocal complex (A~A~.  Our results are shown in  Fig.  1. 
Antibody H116.32 (Fig.  1 d) precipitates A~, A~, and A~ chains from (BbA)F1 spleen 
cells, as seen by comparison with molecules precipitated from the parental strain cells 
(Fig.  1 a, b, c). This pattern indicates recognition  k  k  k  b  of A~A~ and A~A~ molecules via a 
determinant on the A~ chain. Antibody 10-2.16, as previously reported (12), precipi- 
tates  A  k,  A~,  and  A~  chains  from  (BbA)F1  spleen  cells  (Fig.  1 e), which  indicates 
recognition of  k  k  b  k  A~At~ and A~Ap  molecules'via the A~ chain.  A  mixture of I-A  b and 
I-A  k molecules precipitated separately is shown for comparison (Fig. 1 c). In summary, 
our two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis data 
are  most  consistent  with  the  interpretation  that  antibodies  10-2.16  and  Hl16.32 
recognize determinants  on  reciprocal,  hybrid  I-A  molecules  k  b  A,~A~  (Hl16.32)  and 
b  k  A.A~ (10-2.16). These data do not imply that either antibody recognizes determinants 
present on isolated I-A chains. 
Identification  of Hybrid A~t~  and  b  k  A~A~  Molecules  Using  bml2  (A~  Mutant)  Strain 
Cells.  Considerable evidence has been published recently (13-15) documenting the 1190  T  CELL CLONES  SPECIFIC  FOR  HYBRID  I-A MOLECULES 
FIG.  1.  Two-dimensional analysis  of I-A molecules.  (a)  Strain B6 spleen  cell extract precipitated 
with antiserum D-33;  (b)  strain A spleen  cell extract precipitated with monoclonal antibody  10- 
2.16; (c) a mixture of the extracts from strain B6 and A (a and b above); (d)  (B6 X A)F1 spleen cell 
extract  precipitated  with  monoclonal  antibody  Hl16.32.  The  arrows  indicate  characteristic  fib 
polypeptides;  (e)  (B6  ×  A)Ft spleen  cell extract precipitated with monoclonal antibody  10-2.16. 
The arrow indicates  a characteristic a b polypeptide. The mixture of parental  I-A polypeptides is 
included for ease of comparison.  The basic end of the gels is to the left, the acidic end to the right. 
defect  in  LA  b  antigens  of the  mutant  mouse  strain  B6.C-H-2  bin12  (bml2).  Tryptic 
peptide map  comparisons of biosynthetically radiolabeled I-A molecules from B6 and 
bml2  mice have revealed a  small  number  of peptide  changes  in the beta chain,  but 
none in the alpha chain from bml2  mice as compared  with B6 mice (16).  If, indeed, 
only the A~  m12 chain is altered,  then we would predict  that  certain clones recognizing BECK ET AL.  1 191 
TABLE IV 
Antigen Presentation by (B6 X  A)F1 and [bml2 X  BIO.A(4R)]F1  Spleen Cells 
Antigen-presenting cell 
Haplotype  Clones 
K  A  E  D  26.17 myo-  9 KLH  11 KLH 
globin 
(B6 X A)Fx  b  b  b  b  35,053  18,363  15,203 
"k  k  k 
[bm12 X B10.A(4R)]F~  b  b*  b  b  2,428  18,573  260 
k  b  b 
The response, as cpm of [aH]thymidine incorporated, on day 3 of 1 ×  10  4 cloned responder cells to 3 btM 
myoglobin or 50/~g/ml KLH in the presence of 1 × 106 irradiated (3,300 rad) spleen cells. 
* bml2 has a mutation in the A  B  chain (16). 
k  b  the  A~A~ hybrid molecule would  fail  to  be  stimulated  by  [bml2  X  B10.A(4R)]F1 
b  k  spleen  cells,  whereas clones specific for the  A~AB hybrid molecule would recognize 
[bml2  ×  B10.A(4R)]F1  spleen  cells  as  effectively as  they  do  [B6  ×  B10.A(4R)]F1 
b  k  spleen  cells.  We  inferred  that  clones  11.17  and  11.19  recognized the  A~Aa hybrid 
molecule based  on  the  antibody-blocking experiment  shown  in  Table  I,  and  that 
clones  10.39.2  and 23AB1.2 recognized the A~A~ hybrid molecule.  If this is correct, 
then clones  11.17 and  11.19  should be stimulated by [bml2 X  B10.A(4R)]FI spleen 
cells,  whereas clones  10.39.2  and 23AB1.2 might fail to be stimulated.  Similarly, we 
would predict that [bin 12 X B 10.A(4R)]F1 spleen cells could present antigen to KLH- 
reactive clone 9,  but  might  not  to  KLH-reactive clone  11  or to  Mb-reactive clone 
26.17.  As shown in Tables I  and II, alloreactive clones that are blocked by  10-2.16, 
but not H 116.32, respond to determinants on [bm 12 X B 10.A(4R)]F1 cells.  Similarly, 
antigen-reactive  clones  (Tables  III and  IV)  recognizing hybrid  I-A  molecules  on 
antigen-presenting cells exhibited the same pattern: those clones inhibited by antibody 
H 116.32 failed to respond to antigen presented by [bm 12 X B 10.A(4R)]F1 spleen cells, 
whereas clones inhibited by 10-2.16 responded to antigen and Ibm 12 X B 10.A(4R)]F1 
cells.  Thus,  all  of the  data  are  consistent  with  the  interpretation  that  we  have 
distinguished  clones that  recognize each of the two hybrid molecules controlled by 
the  I-A region in H-2~/H-2 b heterozygous mice,  k  b  b  k  A~A~ and A~A~, and  furthermore, 
that in  [bml2 ×  B10.A(4R)]F1 mice one of the molecules,  k  b  A~AB, is not expressed in 
a form recognizable by certain alloreactive and antigen-reactive T  cells. 
Discussion 
We  have  previously  (1,  3,  4,  17)  presented  data  demonstrating  that  among the 
alloreactive and antigen-reactive T  cell clones, we can differentiate those that recog- 
nize I-A and I-E region Ia molecules by mapping the loci controlling expression of the 
molecules. Although it was suspected that there were two possible hybrid molecules 
expressed  in  I-A region  heterozygotes, on  the  basis  of the  two-chain  nature  of Ia 
molecules,  the  lack  of recombinants  within  the  I-A  region  did  not  permit  their 
discrimination  by mapping experiments.  We therefore turned  to using monoclonal 
anti-Ia antibodies to differentially block stimulation of the cloned cell lines. 
In the past, there have been several reports on the ability of anti-Ia alloantisera to 
block stimulation of appropriate MLR  (18,  19). The interpretation  of these experi- 
ments has been that the Ia molecules detected by the alloantisera are the determinants 1192  T  CELL  CLONES  SPECIFIC  FOR  HYBRID  I-A  MOLECULES 
that  stimulate  the  MLR.  However, there  always remained  the  possibility that  the 
alloantisera contained  antibodies  for MLR-stimulating determinants  that were dis- 
tinct  from  Ia  antigens,  but  were  closely  linked  to  them  genetically.  The  recent 
production  of monoclonal anti-Ia antibodies  and isolation of T  cell clones makes it 
possible to do similar experiments in a  more clearly interpretable manner. We used 
several monoclonal anti-I-A  k antibodies  that  had  been produced  and characterized 
previously (6-8). We found that the ability of these antibodies to block the stimulation 
of I-Ak/I-Ab-reactive  clones divided the clones into two groups. Based on the biochem- 
ical analysis, which showed that antibody  10-2.16 reacts with a  determinant  on the 
A~ chain (12), and our two-dimensional gel analysis, which confirmed this and showed 
that  antibody  H116.32  reacts with  the  Ak, polypeptide, we concluded  that  the  F1- 
b  k  recognizing clones blocked by antibody 10-2.16  are reactive with  the A~Aa hybrid 
molecule,  whereas  clones  blocked  by  Hl16.32  are  reactive  with  k  b  A~A~  molecules. 
Furthermore, we would argue that other antibodies that block proliferation of T  cell 
clones  in  a  pattern  identical  to that  of 10-2.16  also recognize determinants  on A~, 
whereas an H116.32-1ike blocking pattern characterizes antibodies reactive with the 
A~ polypeptide. We have preliminary data to suggest that this argument  is correct. 
An  independently  derived anti-I-A  k monoclonal antibody  (provided  by M.  Pierres, 
Centre d'Immunologie, INSERM-CNRS, Marseilles, France), which blocks prolifer- 
ation of clones exactly as 10-2.16 does, also immunoprecipitates the same I-A products. 
Also,  we  can  infer  that  Ia specificity  17  (10-2.16)  and  the  Ia.17-1ike  specificity of 
H 150.13  are A~ determinants, whereas specificities 19 (H 116.32)  and 2 (H 118.49)  are 
related to the A~ chain. The functional data presented in this paper are in complete 
agreement with competitive antibody-binding studies  (7)  showing close proximity of 
binding sites for antibodies  10-2.16  and  H150.13.  These sites  are distant  from sites 
recognized by antibodies H 116.32  and H 118.49,  which are, conversely, close to each 
other. 
The  mutant  mouse  strain  B6.C-H-2  bm12 provides  us  with  an  additional  line  of 
evidence  that  MLR-stimulating  determinants  and  restriction  elements  for  antigen 
presentation are Ia molecules (11).  The bm 12 mutant was originally discovered as a 
gain-and-loss spontaneous mutant by skin grafting (13).  By complementation studies, 
the mutation mapped to the I-A region, and later serological analysis demonstrated 
the absence of specificity Ia.8 and the reduction of specificities Ia.3, 9,  15, and 20 on 
spleen cells of bml2 mice (14,  15). McKean et al.(16), using tryptic peptide analysis, 
have recently found that the A~  m12 chain isolated from bml2 spleen cells differs from 
the normal  B6 A~ chain.  We examined whether  cells from  [bml2  ×  B10.A(4R)]F1 
mice would express the MLR-stimulating determinants or antigen-presenting deter- 
minants recognized by the alloreactive or antigen-specific T  cell clones used in this 
report. We predicted that certain clones that recognized the A~A~ molecule, as defined 
by the antibody-blocking experiments, would not respond to stimulation or antigen 
presentation by [bml2 X B 10.A(4R)]Fa spleen cells. However, [bm 12 X B 10.A(4R)]F1 
b  k  spleen cells should retain the ability to stimulate clones recognizing the A~A~ hybrid 
molecule. This prediction was fulfilled (Tables III and IV). 
We have provided biochemical, genetic, and functional evidence for discrimination 
k  b  b  k  of A~A~ vs. A~A~ hybrid I-A molecules by T  cell recognition. Although the results of 
any one line of evidence are insufficient  to unambiguously document  this discrimi- 
nation, the antibody-blocking data taken together with the biochemical data strongly BECK  ET  AL.  1193 
suggest that these two separate hybrid molecules can serve as stimulating determinants 
or restriction elements for separate sets of T  cell clones. These data and the additional 
line of evidence presented by studying antigen presentation using cells of the bml2 
mouse unequivocally demonstrate that the two sets of clones are recognizing reciprocal 
combinations of alpha and beta A region polypeptides. 
Summary 
Alloreactive and soluble antigen-reactive, I-A-restricted T cell clones were examined 
for  their  ability  to  recognize  hybrid  I-A antigens.  Several  clones  that  recognized 
hybrid  I-Ab/I-A  k  molecules  on  (C57BL/6  ×  A/J)F1  [(B6A)F1]  spleen  cells  were 
studied.  We were able to distinguish clones that recognized hybrid I-A molecules of 
the  b  k  A,Aa type from those that recognized AkA~ molecules. We reached this conclusion 
by considering  data  from three  independent  types of experiments.  (a)  Monoclonal 
antibodies were used to inhibit  T  cell stimulation.  Antibodies  I0.2.16 and HI16.32 
distinguished two mutually exclusive "families" of T  cell clones. One group of clones 
was  inhibited  by  I0-2.16  and  not  HI16.32,  the  other  group  exhibited  reciprocal 
inhibition.  (b)  T  cell  proliferation  was  assayed using  antigen-presenting  cells  from 
B6.C-H-2  bml2 (bml2) and [bml2 ×  BI0.A(4R)]FI mice. Because the bml2 strain has 
a mutation that results in an altered A~ polypeptide chain (A~m12), we reasoned that 
clones that could recognize the  [bm12 ×  B I0.A(4R)]FI cells were recognizing AbA~ 
molecules.  Alternatively,  clones  not  recognizing  [bml2  ×  BI0.A(4R)]FI  cells  had 
specificity for AkA~ molecules.  (c)  I-A molecules immunoprecipitated  from radiola- 
beled (B6A)FI splenocyte extracts were analyzed by two-dimensional sodium dodecyl 
sulfate-polyacrylamide gel  electrophoresis.  These experiments  confirmed  an  earlier 
report that antibody I0.2.16 recognized determinants on the A~ chain (12).  Antibody 
HI16.32  immunoprecipitated  products  consistent  with  recognition  of A k  determi- 
nants. Taken together, these three types of results offer conclusive evidence that T  cell 
clones  recognizing  "hybrid"  I-A molecules  use  either  b  k  k  b  A~Aa or  A~A~  molecules  as 
recognition or restriction  sites.  Clones whose proliferation was supported by Ibm 12 
b  k  ×  B10.A(4R)]F1  cells  and  blocked  by anti-I-A  k antibody  10-2.16  recognized  A,A  B 
molecules.  Clones  that  were  blocked  by  antibody  Hl16.32  and  did  not  recognize 
k  b  [bml2  X  B10.A(4R)]F1  cells use a  recognition site(s)  on A,A~ molecules.  Thus, we 
can demonstrate both functionally and biochemically that hybrid F1 I-A molecules of 
the  structure  AkA~  and  A~A~  both  exist  on  (B6A)F1  splenocytes  and  that  both 
configurations are used in immune recognition phenomena. 
Many thanks to P. D. Infante and T. Kimlinger for technical assistance,  and to T. Lee and L. 
Gatenby for manuscript preparation. 
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